[Form 4] Ambac Financial Group, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ford Motor Company (symbol: F) has filed a Form 144 indicating the proposed sale of 30,000 common shares under Rule 144 of the Securities Act of 1933. The shares will be sold through UBS Financial Services, Inc., 11 Madison Ave., New York, NY 10010, with an aggregate market value of $330,000. The approximate sale date disclosed is 07/01/2025, and the shares are to be listed on the NYSE.

The filing shows that the seller originally acquired the shares via three restricted-stock unit (RSU) vesting events on 03/02/2021 (5,424 shares), 03/04/2022 (13,949 shares) and 03/04/2024 (10,627 shares), matching the total of 30,000 shares to be sold. Ford’s total shares outstanding, as referenced in the filing, are 3,905,696,769; therefore, the proposed sale represents roughly 0.0008 % of shares outstanding—an immaterial fraction from a market-capitalization standpoint.

No prior sales were reported during the last three months, and no remarks or 10b5-1 plan adoption dates were disclosed. The filer has affirmed that he or she is not in possession of undisclosed material adverse information.

Investment take-away: While the notice signals insider intent to liquidate equity worth $330,000, the volume is negligible relative to Ford’s float and should not, by itself, influence the valuation or liquidity of Ford shares.

Positive

• Procedural transparency: Insider followed Rule 144 disclosure requirements before selling shares.
• Immaterial dilution: 30,000 shares represent only 0.0008 % of Ford’s outstanding shares, posing no dilution risk.

Negative

• Insider selling signal: Any insider sale—even if small—can be perceived as a lack of confidence by some investors.

Insights

Equity Analyst

TL;DR: Small insider sale (30k shares, $330k) is routine and immaterial to Ford’s capitalization.

The filing discloses a sale equal to 0.0008 % of Ford’s 3.9 billion shares outstanding—far below thresholds that typically move markets. The shares stem from normal RSU vesting, indicating compensation-related liquidity rather than a strategic divestment. No pattern of recent selling is noted, and the filer certifies absence of undisclosed negative information. For portfolio managers, the transaction is unlikely to impact price discovery, earnings outlook, or governance assessments.

Corporate Governance Specialist

TL;DR: Filing demonstrates procedural compliance; no governance red flags detected.

Rule 144 notice was correctly filed in advance of the trade, specifying broker, share count, and acquisition history. Lack of a 10b5-1 plan date suggests discretionary timing, but the minimal size mitigates governance concerns. The representation that no undisclosed material information exists supports transparency commitments. Overall effect on governance risk profile is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PRICE MICHAEL D

(Last) (First) (Middle)

AMBAC FINANCIAL GROUP, INC.

ONE WORLD TRADE CENTER

(Street)

NEW YORK NY 10007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMBAC FINANCIAL GROUP INC [ AMBC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/01/2025		A		7,053		(2)	(2)	Common Stock	7,053	$0	39,179	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").

2. RSUs granted on July 1, 2025 shall vest one year later on July 1, 2026. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.

Remarks:

	William J. White, attorney in fact	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Ford’s Form 144 filed on 07/01/2025 disclose?

It discloses a proposed sale of 30,000 Ford common shares valued at $330,000 under Rule 144.

How significant is the 30,000-share sale relative to Ford’s float?

The sale equals about 0.0008 % of the 3.9 billion shares outstanding, an immaterial amount.

When were the shares being sold originally acquired?

Through RSU vestings on 03/02/2021 (5,424 shares), 03/04/2022 (13,949), and 03/04/2024 (10,627).

Which broker will execute the sale for the insider?

The trade is to be executed by UBS Financial Services, Inc., New York.

Does the filing mention a Rule 10b5-1 trading plan?

No date of plan adoption or instructions under Rule 10b5-1 was provided in the filing.